We are live on ! Find out more
ONCE

Spark Therapeutics, Inc. Common Stock
ONCE

Delisted

ONCE was delisted on the 16th of December, 2019.

Back to rankings

95 hedge funds and large institutions have $904M invested in Spark Therapeutics, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 95 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

37% more call options, than puts

Call options by funds: $885K | Put options by funds: $646K

Holders
95
Holders Change
+95
Holders Change %
–
% of All Funds
2.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
95
Increased
–
Reduced
–
Closed
–
Calls
$885K
Puts
$646K
Net Calls
+$239K
Net Calls Change
+$239K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$90.5M
2
BBA
Baker Bros. Advisors
New York
+$76.4M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$69.4M
4
DM
Deerfield Management
New York
+$36.4M
5
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$30.8M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
26
Artal Group
Luxembourg
$4.65M +$3.46M +60,000 New
EAM
27
EverPoint Asset Management
Connecticut
$4.65M +$3.46M +60,000 New
CS
28
Candriam SCA
Luxembourg
$4.26M +$3.17M +55,000 New
TA
29
Teachers Advisors
New York
$4.09M +$3.04M +52,754 New
Fidelity International
30
Fidelity International
Bermuda
$3.97M +$2.95M +51,235 New
Ameriprise
31
Ameriprise
Minnesota
$3.49M +$2.6M +45,088 New
JP Morgan Chase
32
JP Morgan Chase
New York
$3.33M +$2.48M +42,998 New
Alyeska Investment Group
33
Alyeska Investment Group
Illinois
$3.3M +$2.45M +42,618 New
CWG
34
C WorldWide Group
Denmark
$2.87M +$2.13M +37,000 New
Asset Management One
35
Asset Management One
Japan
$2.64M +$2.05M +35,610 New
RSCM
36
Rock Springs Capital Management
Maryland
$2.57M +$1.91M +33,106 New
BlackRock
37
BlackRock
New York
$2.56M +$1.9M +32,977 New
BIM
38
BlackRock Investment Management
Delaware
$2.54M +$1.88M +32,715 New
Bank of New York Mellon
39
Bank of New York Mellon
New York
$2.48M +$1.84M +32,031 New
Axa
40
Axa
France
$2.48M +$1.84M +31,954 New
Massachusetts Financial Services
41
Massachusetts Financial Services
Massachusetts
$2.17M +$1.61M +28,014 New
B
42
Bailard
California
$2.17M +$1.61M +28,000 New
ACH
43
ArrowMark Colorado Holdings
Colorado
$1.96M +$1.46M +25,337 New
PAM
44
Panagora Asset Management
Massachusetts
$1.96M +$1.46M +25,306 New
Northern Trust
45
Northern Trust
Illinois
$1.57M +$1.17M +20,287 New
EA
46
Emerald Advisers
Pennsylvania
$1.4M +$1.45M +25,099 New
Principal Financial Group
47
Principal Financial Group
Iowa
$1.39M +$1.04M +18,000 New
EI
48
EAM Investors
California
$1.39M +$1.03M +17,954 New
MIG
49
Mariner Investment Group
New York
$1.3M +$965K +16,750 New
NIP
50
Nicholas Investment Partners
California
$1.29M +$961K +16,684 New
1
2
3 4

ONCE Hedge Fund Activity: Q1 2015 in Review

95 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Spark Therapeutics, Inc. Common Stock (ONCE) for Q1 2015, worth a combined $904M.

Buyers outnumbered sellers: 95 funds opened new ONCE positions and 0 closed out — a net gain of 95 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $90.5M.

  • 95 institutional investors held Spark Therapeutics, Inc. Common Stock (ONCE) as of Q1 2015, up from 0 in Q4 2014.
  • Funds reported $904M of Spark Therapeutics, Inc. Common Stock stock for Q1 2015.
  • 95 funds opened new Spark Therapeutics, Inc. Common Stock positions in Q1 2015 and 0 closed out, a net change of +95 holders.
  • The largest Spark Therapeutics, Inc. Common Stock buyer in Q1 2015 was Fidelity Investments, an estimated $90.5M added.

Based on aggregated 13F filings for Q1 2015.